Publications by authors named "I Nafia"

Claim this Profile
A
AT-0174, a novel dual IDO1/TDO2 enzyme inhibitor, synergises with temozolomide to improve survival in an orthotopic mouse model of glioblastoma.
Michael J Bickerdike, Imane Nafia, Alban Bessede, Cheng-Bang Chen, Medhi Wangpaichitr

BMC Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non-Small Cell Lung Cancer.
Alban Bessede, Florent Peyraud, Benjamin Besse, Sophie Cousin, Mathilde Cabart, Imane Nafia

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non-Small Cell Lung Cancer.
Alban Bessede, Florent Peyraud, Sylvestre Le Moulec, Sophie Cousin, Mathilde Cabart, Imane Nafia

Clin Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors.
F Peyraud, J-P Guégan, D Bodet, I Nafia, L Fontan

Ann Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of acetaminophen on the efficacy of immunotherapy in cancer patients.
A Bessede, A Marabelle, J P Guégan, F X Danlos, S Cousin, I Nafia

Ann Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis